脱硫弧菌在炎症相关性结肠癌发生中的作用机制
批准号:
81972225
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
孙蕴伟
依托单位:
学科分类:
肿瘤发生
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
孙蕴伟
中文摘要
肠道菌群失调在炎症性肠病(IBD)及炎症相关性结肠癌(CAC)发生发展中具有重要作用。我们前期研究发现,在CAC模型小鼠肠道中脱硫弧菌显著增多,且以乳酸杆菌为主的益生菌复合物预防性治疗可显著降低脱硫弧菌含量,减少肠道肿瘤形成。进一步研究发现肠道粘膜脱硫弧菌含量与COX2-PGE2-CXCR2信号通路具有显著相关性。基于此,我们推测脱硫弧菌可能通过激活CXCR2信号轴来发挥其促炎促癌作用。因此,本项目拟利用脱硫弧菌定植伪无菌鼠以及化学诱导方法建立脱硫弧菌诱导的IBD-CAC小鼠模型,研究脱硫弧菌在IBD-CAC发生及发展中的具体作用,并对脱硫弧菌与COX2-PGE2-CXCR2信号通路的关系做进一步探索。本项目的完成有助于阐明在炎症性肠病恶性转化过程中脱硫弧菌的具体作用及内在机制。借此丰富肠道菌群与炎症/肿瘤调控网络理论,为IBD恶性转化治疗提供新策略和理论依据。
英文摘要
Intestinal flora plays a fundamental role in the initiation and progression of inflammatory bowel disease and Colitis-Associated Colorectal Cancer (CAC). Our previous study indicated that the Desulfovibrio was significantly increased in the colon tissues of CAC model mice, and prophylactic treatment with Lactobacillus-based probiotics could significantly reduce the relative abundance of Desulfovibrio and reduce the tumor formation. Further study demonstrated that Desulfovibrio was significantly correlated with COX2-PGE2-CXCR2 signaling pathway. Therefore, our project intends to establish a Desulfovibrio-CAC mouse model using the pseudo-sterile mice and chemical-induced methods and figures out the critical role of the Desulfovibrio in the initiation and progression of CAC. The downstream mechanisms concerning Desulfovibrio and COX2-PGE2-CXCR2 signaling pathway are necessary to be elucidated. The completion of this project will be instrumental to clarify the specific relationship between Desulfovibrio and colonic tumorigenesis. The project also can enrich the theory of regulatory network inculding gut microbiota and inflammation / tumor, and provide new strategies and theoretical basis for the treatment of IBD-CAC transformation.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Glutamate dehydrogenase enables Salmonella to survive under oxidative stress and escape from clearance in macrophages
谷氨酸脱氢酶使沙门氏菌能够在氧化应激下生存并逃避巨噬细胞的清除
DOI:
10.1002/1873-3468.14247
发表时间:
2021-12
期刊:
FEBS LETTERS
影响因子:
3.5
作者:
[Huang Xi, Lao Wenji, Zhou Youci, Sun Yunwei, Wang Qijun]
通讯作者:
Wang Qijun
DOI:
10.15252/embj.2022112333
发表时间:
2023-05-15
期刊:
EMBO JOURNAL
影响因子:
11.4
作者:
[Sun,Yunwei, Zhang,Yuebin, Wang,Qijun]
通讯作者:
Wang,Qijun
DOI:
10.1016/j.plipres.2022.101178
发表时间:
2022
期刊:
Progress in Lipid Research
影响因子:
作者:
[Xi Huang, Youci Zhou, Yunwei Sun, Qijun Wang]
通讯作者:
Qijun Wang
联合干扰素及表皮生长因子受体阻断剂治疗胃肠道肿瘤-靶向诱导XAF1基因表达过程中相关信号传导通路的研究
-
批准号:81072010
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:孙蕴伟
-
依托单位:
干扰素诱导基因XAF1的分子调控机制研究
-
批准号:30600283
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2006
-
负责人:孙蕴伟
-
依托单位:
国内基金
海外基金